New anxiety drug shows promise in early trial
NCT ID NCT06051721
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 26 times
Summary
This study tests a new medication called CYB004 for people with generalized anxiety disorder (GAD). The goal is to see if it safely reduces anxiety symptoms. About 36 adults with moderate to severe GAD will take either CYB004 or an active control. Researchers will measure anxiety levels using a standard scale and monitor side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED ANXIETY DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedar Clinical Research
Murray, Utah, 84107, United States
-
CenExel ACMR
Atlanta, Georgia, 30331, United States
-
Innovative Clinical Research, Inc.
Miami Lakes, Florida, 33016, United States
-
Research Centers of America
Hollywood, Florida, 33024, United States
-
Uptown Research Institute
Chicago, Illinois, 60640, United States
-
iResearch Atlanta
Decatur, Georgia, 30330, United States
Conditions
Explore the condition pages connected to this study.